Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

NewsGuard 100/100 Score

A very interesting case report appeared recently on the Journal of Travel Medicine, describing the real-life secondary attack rate of the Delta variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on a single naval ship. The findings are highly relevant to the debate on the protection afforded by vaccination against the virus.

Study: A high attack rate of 90% of SARS-CoV-2 Delta variant infections in crew personnel on a single navy ship. Image Credit: Corona Borealis Studio/ ShutterstockStudy: A high attack rate of 90% of SARS-CoV-2 Delta variant infections in crew personnel on a single navy ship. Image Credit: Corona Borealis Studio/ Shutterstock

Background

The coronavirus disease 2019 (COVID-19) pandemic has seen multiple waves of transmission occurring in different regions worldwide. Many viral mutations have also been reported, resulting in the emergence of several new strains of the virus. These include the Alpha, Beta, Gamma, and Delta variants of concern (VOCs), so-called because they have increased transmissibility, immune evasion, or virulence characteristics compared to the wild-type strain.

The current report sheds light on the sudden and rapid rise to dominance of the Delta strain of the virus, from its first appearance in the first part of the year, using the story of its spread on board a navy ship off the coast of the African continent.

What did the study show?

The ship, a navy destroyer serving in the Gulf of Guinea, off the western African coast, had 301 soldiers aboard carrying out various missions. All the soldiers were healthy, and none had received any COVID-19 vaccine.

Of these, >90% (272) were infected with the virus, specifically the Delta variant. This shows the extreme transmissibility of this variant compared to the earlier lineages and indicates the extent of spread among a susceptible, unvaccinated population in close proximity to each other.  

Of the total 272 infected soldiers, approximately 77%, or 209 soldiers, developed COVID-19 symptoms. About 6% of the infected soldiers developed symptoms that warranted hospitalization. More than 2% of the total cases were moderate to severely symptomatic.

The navy ship left a Korean harbor, in East Asia, on February 8, 2021, heading for the final location in the Gulf of Guinea, where it was slated to carry out its missions. It remained at the harbor in the Gulf of Guinea from June 28, 2021, to July 1, 2021. The next day, the first symptom of COVID-19 was reported.

On July 5, 2021, the soldiers were required to wear face masks and observe social distancing. Yet, on July 6, six cases of Delta infection were reported, which zoomed up to 247 cases over the next ten days. This reached its maximum of 272 on July 26, 2021.

That is, over 90% of the ship’s crew was infected within 25 days.

Polymerase chain reaction (PCR) testing was carried out on all the soldiers on the ship. The samples taken from 64 soldiers were subjected to further genomic tests to determine the variant. All showed the presence of the Delta variant of concern (VOC), which has been responsible for the explosive spread of the virus over most of the world in recent months.

Based on this, the researchers assumed that 100% of confirmed infections were due to this variant. The vaccine was unavailable during the mission. The entire crew was flown by special aircraft to a designated airport in Korea by July 20, 2021. All infected personnel recovered and were discharged by August 10, 2021.

What are the implications?

The researchers point out several takeaways from this episode in the ongoing pandemic. First, the Delta variant affected over 90% of a healthy unvaccinated population on board, indicating that the same extent of spread may be expected in an exposed naïve unvaccinated population, which would contain some immunocompromised individuals at least, besides healthy people.

Secondly, the study results show that most healthy people are asymptomatic or develop only mild symptoms once infected. About 6% required hospitalization, however, and more than 2% developed moderate to severe symptoms.

Finally, this study shows the rapidity with which the Delta variant spreads within a restricted space. The reporting of the first symptom of COVID-19 on board the ship on July 2, 2021, was followed by a rapid surge of cases to 247 by July 14, 2021.

The reasons put forward to explain this kind of spread include the very crowded conditions on board the ship, within confined spaces. Social distancing is difficult to achieve in this situation, with multiple and repeated contacts occurring between the soldiers. This could account for the >90% secondary attack rate.

The aerosol spread of the Delta virus within such crowded and poorly ventilated spaces would further accelerate the spread of the virus. Both this and other respiratory viruses have been demonstrated to be highly contagious onboard ships, including cruise ships earlier.

In this study, medical records and demographic data were not made available for obvious reasons. Nonetheless, the study illuminates the transmission of this VOC in overcrowded conditions, with limited potential for physical distancing, and with repeated multiple contacts over the course of a day between the inhabitants of the space.

This massive infection outbreak on a single navy ship clearly mirrors the contagious characteristics of the SARS-CoV-2 Delta VOC.”

Journal reference:
  • Lee, B. (2021) "A high attack rate of 90% of SARS-CoV-2 Delta variant infections in crew personnel on a single navy ship", Journal of Travel Medicine. doi: https://doi.org/10.1093/jtm/taab168
Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2022, November 21). Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship. News-Medical. Retrieved on April 26, 2024 from https://www.news-medical.net/news/20211101/Real-life-SARS-CoV-2-Delta-variant-secondary-attack-rate-on-naval-ship.aspx.

  • MLA

    Thomas, Liji. "Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship". News-Medical. 26 April 2024. <https://www.news-medical.net/news/20211101/Real-life-SARS-CoV-2-Delta-variant-secondary-attack-rate-on-naval-ship.aspx>.

  • Chicago

    Thomas, Liji. "Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship". News-Medical. https://www.news-medical.net/news/20211101/Real-life-SARS-CoV-2-Delta-variant-secondary-attack-rate-on-naval-ship.aspx. (accessed April 26, 2024).

  • Harvard

    Thomas, Liji. 2022. Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship. News-Medical, viewed 26 April 2024, https://www.news-medical.net/news/20211101/Real-life-SARS-CoV-2-Delta-variant-secondary-attack-rate-on-naval-ship.aspx.

Comments

  1. Dez Bunsie Dez Bunsie Canada says:

    52 people all vaccinated were all infected. 25 were asymptomatic. 25 had mild to severe symptoms. 25% were hospitalized.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study highlights how age affects nasal cell response to SARS-CoV-2